Under construction – not a live service
Sign in
Taking people in NetherlandsPhase 1

A study to investigate the safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of a single subcutaneous dose of GSK4771261 in healthy participants aged 25 to 55 years of age inclusive

Key facts

Where
Groningen, NetherlandsSee the site
Phase
Phase 1

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Source: 2025-525073-37-00, who can take part

Where in Netherlands

  • Pharmaceutical Research Associates Group B.V.Groningen, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Glaxosmithkline Research & Development Limited
Trial code
EU 2025-525073-37-00
Record updated
22 September 2026
Under construction, not live – A study to investigate the safety, tolerability, pharmacokinetics, immunogenicity and pharmacodynamics of a single subcutaneous dose of GSK4771261 in healthy participants aged 25 to 55 years of age inclusive (2025-525073-37-00) – Frontlight Research